ID
24727
Description
Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00480181
Link
https://clinicaltrials.gov/show/NCT00480181
Keywords
Versions (1)
- 8/15/17 8/15/17 -
Uploaded on
August 15, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Neuropathic Pain NCT00480181
Eligibility Neuropathic Pain NCT00480181
- StudyEvent: Eligibility
Similar models
Eligibility Neuropathic Pain NCT00480181
- StudyEvent: Eligibility
C0751967 (UMLS CUI [2])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C3242229 (UMLS CUI [1,4])
C1457887 (UMLS CUI [1,2])
C0042815 (UMLS CUI [1,3])
C3714625 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0430061 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C2828389 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C2828389 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0570597 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0068333 (UMLS CUI [3,2])
C1527240 (UMLS CUI [3,3])
C2828389 (UMLS CUI [1,2])
C1514468 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])